Measurement of Procalcitonin in acute exacerbation of COPD and its correlation to Spirometric Indices
Journal Title: International Journal of Research and Development in Pharmacy & Life Sciences (IJRDPL) - Year 2017, Vol 6, Issue 6
Abstract
Background: rational prescription of antibiotics in acute exacerbation of COPD (AECOPD) requires predictive markers. Acute phase reactants are capable of demonstrating the inflammation; however, they cannot be employed to make a difference between bacterial and non-bacterial causes of the inflammation. The bacterial infection plays an important role in the exacerbation of COPD patients. Recently, measurement of serum procalcitonin levels appears to be useful in order to minimize this problem. We aim to evaluate the prognostic and diagnostic Methods & methods: 51 COPD patients with bacterial exacerbations, 47 patients without bacterial exacerbations, similar age and sex were included in the study. PCT levels in the serum samples were measured in all subjects. Results: Procalcitonin levels ranged from 0.01 to 12.03 ng/ml. Mean levels were 3.18±2.60 ng/ml in Group I and 0.23±0.39 ng/ml in Group II. Median values in Groups I and II were 2.98 and 0.09 ng/ml respectively. Statistically, there was a significant difference between two groups (p<0.001) with Group I showing a higher mean value as compared to Group II. A significant near strong correlation was observed between TLC levels and serum Proclacitonin levels (r=0.699; p<0.001). However, a weak negative and borderline significant correlation. Conclusions: This study found increased PCT serum levels among AECOPD patients and suggests a role for PCT in the predicting of the bacterial exacerbations and their needs for ventilator support. We recommend other large studies to augment our findings.
Authors and Affiliations
Ravi Bhaskar| Department of Pulmonary Medicine, Career Institute of Medical Sciences, Lucknow, India, Seema Singh| Department of Respiratory Medicine, King Georges Medical University, Lucknow, India, Pooja Singh| Department of Pulmonary Medicine, Career Institute of Medical Sciences, Lucknow, India, Sandeep K Singh| Guru Ghashidas Vishvhidhalaya, Bilaspur, Chattisgarh, India, Pooja Singh Gaur| Department of Biotechnology, Amity University, Lucknow, India, Sarika Pandey| Department of Respiratory Medicine, King Georges Medical University, Lucknow, India
Keywords
Related Articles
- EP ID EP16049
- DOI http://dx.doi.org/10.21276/IJRDPL.2278-0238.2017.6(6).2833-2
- Views 307
- Downloads 16
THE COST OF TREATMENT SERVICES IN SALMAN FARSI HOSPITAL OF BUSHEHR
This study aimed to ma te the cost of treatment services in Salman Farsi Hospital of Bushehr. In this study, activity-based cost calculation method was used to calculate the costs. The results showed that internal inten...
Synthesis, characterization, antimicrobial and antitubercular activity of Some Pyrazoline derivatives from Chalcones bearing indane-1,3-dione as nucleus
A series of phenyl pyrazoline derivatives have been synthesized from chalcones of indane-1,3-dione. The substituted chalcones have already been synthesized and reported by us. The phenyl pyrazoline derivatives were syn...
Optimization of Diesel oil degrading Bacterial strains at various culture parameters
Environmental pollution with petroleum has been recognized as one of the most serious current problems. Petroleum hydrocarbons are a combination of hydrocarbons obtained from reservoirs of crude petroleum. The petroleu...
ELECTRONIC TRIAL MASTER FILE (eTMF) - AN INDISPENSABLE TOOL THAT COLLECTS AND FILES ESSENTIAL DOCUMENTS OF A CLINICAL TRIAL: A REVIEW
Every organization involved in clinical trials in the BioPharma industry maintains a trial master file comprised of thousands of pages of regulatory documents required for each clinical trial. Managing thousands of clin...
IMPORTANCE OF ROLE OF PHARMACIST MEDIATED ADHERENCE IN HYPERTENSIVE PATIENTS A BRIEF OVERVIEW
Hypertension is an important risk factor for cardiovascular disease, the incidence of which it is possible to reduce by prophylactic treatment with antihypertensive drugs. Adherence to long-term therapies for chronic di...